The present review summarizes the results of all published papers on whole-body protein turnover in man measured by [ The pros and cons of the two methods are compared and it is suggested that there is a place for further work by the less invasive end-product method, particularly for population studies of the genetic, environmental and functional determinants of whole-body rates of protein synthesis. Protein turnover describes the continual synthesis and breakdown of protein in the body. It is a fundamental biological process in all living organisms, and over the last 50 years workers have attempted to quantify rates of turnover. At the present time the 'gold standard' method of measuring protein turnover in the whole body in man is the 'precursor' method, in which labelled leucine is given by intravenous (IV) infusion for two or more hours until a steady state of enrichment has been achieved in plasma leucine. The purposes of the present review are: to assess what has been achieved over the years by an alternative and historically earlier method, the end-product approach with [ 15 N]glycine; to examine as far as possible the validity of the method by comparing its results with those of the precursor method; to look at the pros and cons of the two methods. The end-product approach would be particularly useful for population studies, which could help to unravel the determinants of individual variation. It is also more easily applied in difficult situations outside a hospital or metabolic ward, as in the studies of Stein et al. (1996) on weightless subjects during a space flight or those of Stroud et al. (1996) during a crossing of Antarctica. We believe that a wider use of the end-product method would help to extend our knowledge of the extremely important biological function, protein turnover.
Protein turnover describes the continual synthesis and breakdown of protein in the body. It is a fundamental biological process in all living organisms, and over the last 50 years workers have attempted to quantify rates of turnover. At the present time the 'gold standard' method of measuring protein turnover in the whole body in man is the 'precursor' method, in which labelled leucine is given by intravenous (IV) infusion for two or more hours until a steady state of enrichment has been achieved in plasma leucine. The purposes of the present review are: to assess what has been achieved over the years by an alternative and historically earlier method, the end-product approach with [ 15 N]glycine; to examine as far as possible the validity of the method by comparing its results with those of the precursor method; to look at the pros and cons of the two methods. The end-product approach would be particularly useful for population studies, which could help to unravel the determinants of individual variation. It is also more easily applied in difficult situations outside a hospital or metabolic ward, as in the studies of Stein et al. (1996) on weightless subjects during a space flight or those of Stroud et al. (1996) during a crossing of Antarctica. We believe that a wider use of the end-product method would help to extend our knowledge of the extremely important biological function, protein turnover.
The first paper in which the end-product method was used to measure whole-body protein turnover appeared more than 50 years ago (Sprinson & Rittenberg, 1949) . These authors used a single oral dose of [ 15 N]glycine and urinary urea as end product. For various reasons (Waterlow et al. 1978a ) the method fell into disuse for many years. It was taken up again and modified by Picou & Taylor-Roberts (1969) , who gave the tracer as a continuous infusion by IV and intragastric routes. A further modification was the introduction of a second end product, ammonia, instead of or combined with urea for the calculation of flux, since ammonia has a small pool that turns over very rapidly (Golden & Waterlow, 1977; Waterlow et al. 1978b) . All the results presented in the present review were obtained with [ 15 N]glycine as tracer and both end products combined.
Theory and practice
The simple two-pool model on which the method was originally based is shown in Fig. 1 . The end-product method derives from the axiom that two products of the same precursor have the same activity (radioactivity or enrichment) provided that the precursor pool is the only source of the products (Zilversmit, 1960) . The assumption then is that the activity of the end product reflects that of the amino-N mixture that is taken up into protein. This mixture does not, of course, have the same amino acid composition as the total free amino-N pool or the plasma pool. An alternative formulation of this assumption is that the proportions of the flux, Q, that go to synthesis and excretion are the same as the proportions of the tracer dose that go to synthesis and excretion. The crucial measurement is therefore that of the flux: once that is determined, synthesis can be derived from the relation S ¼ Q 2 E T ; where S is synthesis and E T is total N excretion. It is important to distinguish between the total N loss, E T , and the loss in the end product, urea or ammonia. In practice the excretion of urea-N þ ammonia-N is usually taken as an approximation to E T , since other sources of urinary N loss and faecal loss can be neglected, being small in comparison with the flux.
Single dose method
Following on from the above, if the tracer is given as a single dose, either by oral or IV route, the flux is defined by the relation: E epðtÞ =Q ðtÞ ¼ e epðtÞ =d;
where d is the dose of tracer, E ep is the amount of end product excreted, e is the amount of tracer excreted in the end product and Q is the flux. t refers to the time period over which the excreted end product is collected. Since e ep /E ep is the 15 N enrichment, 1 in the total collection, the equation can be rewritten:
Q ðtÞ ¼ d=1 t : Fig. 2 shows the time course of the excretion of 15 N in urinary ammonia and urea after a single dose of [ 15 N]glycine. By 9-12 h the excretion of 15 N -labelled ammonia is virtually complete, but that is not the case with urea. To compensate for this, a blood sample is taken after 9 -12 h and the amount of [
15 N]urea retained is determined as the product of plasma [
15 N]urea concentration and an estimate of total body water (Watson et al. 1980) , it being assumed that urea is uniformly distributed in the water of the body. The retention of [
15 N]urea after 9-12 h is usually found to be about 25 % of the dose. Grove & Jackson (1995) suggested that the blood sample taken at 9 h could be replaced by measurement of the amount of labelled urea excreted between 9 and 24 h after the dose of tracer. With ammonia as end product, which turns over rapidly, this extra time of collection could introduce a small but appreciable error from recycling into the ammonia pool of tracer derived from the breakdown of labelled protein; with urea, which turns over more slowly, this source of error can be neglected. It is obviously essential that the collection of urine after the single dose of tracer should be complete, particularly in the first hours. It is possible to divide the 9 h collection into 3 h periods, and to measure the creatinine content of each sample as a check on the completeness of collection.
Multiple oral or continuous infusion
An alternative to the single dose method is to give the tracer by either continuous IV or oral intragastric infusion. More often oral doses are given every hour or so, with food, so that measurements by this multiple or intermittent dose method are almost invariably in the fed state. When the enrichment of the end product has reached a steady state (plateau) 1, _ Q ¼ _ d=1, where the dots represent rates (amounts/time). This method does not require complete urine collections; its disadvantage is the time needed to reach plateau enrichment in urea 224 to 30 h in children, about 60 h in adults -although this time can be reduced by giving a priming dose of [
15 N]glycine at the beginning of the study (Dietz et al. 1982; Jeevanandam et al. 1985; Grove & Jackson, 1995) . Results of comparing single and multiple dose methods are discussed later.
By either method, if a steady state is assumed, synthesis and breakdown (B) can be obtained from the flux by the relation:
where E T is total urinary N excretion, not excretion only of end product, I is intake and N is de novo synthesis.
It should be noted that the end-product method measures fluxes as uptake into synthesis and excretion, so that Q ¼ S þ E, and N does not enter into it. The precursor method measures Q from the dilution of tracer by amino acid entering from all sources, so that if the tracer is a non-essential amino acid N has to be taken into account.
The concept of metabolic channelling
The formulation set out earlier assumes a single homogeneous precursor pool. As soon as ammonia began to be used as an end product it was realized that it seldom produces the same estimates of flux as urea, and the difference varied with the conditions of measurement, whether in the fasted or fed state and whether the tracer was given by oral or IV route. The estimate of flux based on ammonia is designated Q A , that on urea Q U . It is important to recognize that these are not separate fluxes, Grove & Jackson, 1995.) but different estimates of a single flux: that of whole-body amino-N. It was therefore necessary to abandon the original concept of a single homogeneous 'metabolic' pool, and to postulate two pools, spatially and metabolically separate, at least to some extent. The model proposed by Fern et al. (1985a) is shown in Fig. 3 . It is suggested that Q A is 'biased' towards the peripheral tissues, since urinary ammonia is derived mainly from glutamine (Pitts & Pilkington, 1966) , which is synthesized mainly in muscle; and Q U is 'biased' towards the viscera, since urea is synthesized exclusively in the liver; hence the concept of spatial separation of the two estimates of flux. Fern et al. (1981) also pointed out that Q A and Q U tended to vary inversely, which suggested that the best estimate of the 'true' flux is the average of the two different estimates. The flux is the inverse of the end products' activity. There are therefore two possible averages: the arithmetic average ðQ A þ Q U Þ=2, which implies equal amounts of tracer going through the two pathways the harmonic average 2=½ð1=Q A Þ þ ð1=Q U Þ, which implies equal activities in the two pathways. In practice these two averages seldom differ significantly; the arithmetic average is more convenient and will be used throughout the rest of the present review, abbreviated Q av and S av .
[
N]glycine as tracer
The early work on protein turnover was done almost exclusively with [ 15 N]glycine because it was easily available and cheap. Fern investigated the appropriateness of glycine as a tracer in a remarkable experiment. He compared nine different 15 N-labelled amino acids or proteins, and also single oral v. IV dosage, all in one subject -himself (Fern et al. 1985b) . The results are shown in Table 1 . Taruvinga et al. (1979) obtained similar results in rats infused with four different amino acids and measurements of enrichment of urea and ammonia in liver and kidney. Fig. 3 is a possible scheme for interpreting these findings. Since the basic assumption of the end-product method is that the enrichment of N in the end products' precursor pools is the same as in the precursor pool for synthesis, if tracer is diverted towards the end products, so that 1 becomes 1 þ where e stands for enrichment, the estimates of flux and synthesis will be falsely low. This is what seems to be happening with alanine and glutamine, the main N transporters, to produce very low estimates of flux and synthesis by both routes of dosage. On the other hand, Jackson & Golden (1980) found no labelling of plasma alanine and glutamate after giving [
15 N]glycine, a discrepancy that we cannot explain. Aspartate and glutamate are pre-eminent as transaminators. The low flux ratio, Q A /Q U , when these amino acids are given orally implies a greater flux through the visceral tissues, consistent with their known role in urea formation. The low flux ratio with leucine, by both rates of dosage, is consistent with the leucine -ketoacid transaminase being located mainly in muscle. Finally, with lysine estimates of flux are uniformly high, indicating very little labelling of the end products' precursor pools. This might be expected, since lysine is not transaminated; it was shown by Ä qvist (1951) that of all the amino acids lysine has the least exchange of N with other amino acids and by Read et al. (1971 Read et al. ( , 1972 This interpretation of Fern's data is inevitably speculative, but it may be reasonable to suppose that an amino acid is more likely to give a 'correct' estimate of whole-body flux the more closely two conditions are fulfilled:
(1) If similar estimates are given by the two end products, i.e. if the flux ratio does not deviate too far from unity, so that the common precursor pool can be regarded as more or less homogeneous; (2) If the same value for Q av is obtained by the two routes of tracer entry, oral and IV.
These two points minimize the metabolic and the spatial separation postulated in the model of Fig. 3 . On the basis of these criteria glycine is clearly the best: Q av is the same by oral and IV routes and Q A /Q U shows the smallest deviation from unity.
Support for the use of glycine as a tracer comes from a littlequoted paper by Matthews et al. (1981) . After oral dosage of observed enrichment if the pattern of 15 N in the precursors of urea was exactly the same as the pattern in plasma amino acids. There was, in fact, quite good agreement: calculated enrichment 0·38, observed 0·44 atom% excess. Further support from the protein side came from the demonstration by Bier & Matthews (1982) that with glycine the distribution of 15 N in the amino acids isolated from plasma albumin was similar to that of free amino acids in plasma. It is regrettable that there have not been more such studies.
Analysis of measurements of protein turnover by the endproduct method with [ 15 N]glycine
We attempted to find all studies of protein metabolism in man that had been carried out using the end-product method and [ 15 N]glycine. Many papers were already known to us. We searched Medline, Embase and the ISI Science Citation Index databases. We excluded abstracts, letters, PhD theses, book chapters and review articles where data had previously or subsequently been published, to avoid repetition. We found 212 papers that used [
15 N]glycine and the end-product method. Of these, seventy-seven were included in the tables that follow. The criteria for inclusion were that both end products, ammonia and urea, had been used to calculate results, the number of subjects was reported and that, in studies in the fed state, the protein intake was within a reasonably normal range of 0·5-1·5 g/kg body mass per d.
The analysis included normal adults, children, pregnant women, the elderly and patients in various pathological states. In many of the papers more than one group of subjects was studied. We have reported both synthesis rates and flux ratios.
Comparison of different protocols in the same individuals
Initially we shall consider studies in which the comparisons were made in the same individuals.
Oral v. intravenous dosage of tracer. Fern et al. (1981) compared the results with a single dose of [
15 N]glycine in the same four subjects. There was no difference between oral and IV dosage in either the fed or the fasted state, but the fasted level was only 60 % that in the fed state. In another study , when measurements were repeated on the same individual at different times, there was again no difference between oral and IV routes of dosage. Single v. multiple dosage or constant infusion. The best comparison of the two protocols is one by Grove & Jackson (1995) in which both protocols were carried out in the same person in eleven out of thirteen subjects. In the single dose method urine was collected for 9 h, with corrections for 15 N retained in the urea pool; in the multiple dose method tracer was given orally every 3 h for 15 h. With both methods the subjects were fed every 3 h. The multiple dose method gave values for flux that on average were 25 % lower than those with the single dose method. Two factors may have contributed to this discrepancy: with the multiple dose method a rather large priming dose of [ 15 N]glycine was given 6 h before the multiple doses began, in order that plateau labelling should be achieved in 24 h. This dose may not all have been disposed of by the end of the study; at the same time the 15 h period of dosage may have allowed some re-entry of tracer from protein breakdown into the ammonia pool.
Variability. A study by Fern et al. (1984) allows an estimate of the intrinsic variability of the method when measurements were repeated on the same two subjects over a period of 3 -4 years. The results are shown in Table 2 . The CV were of the order of 5 -6 %, with, as mentioned earlier, no difference between oral and IV dosage. In five other subjects measured on two occasions at intervals of 25 -66 weeks, the mean difference between the two measurements was 10 %. Of course, there may have been real temporal changes. Glynn et al. (1988) made two studies, at an interval of 1 month, on a patient with Guillain-Barré syndrome. The tracer was given IV over 1 h and the patient was fed by nasogastric tube. Synthesis rates differed by only 4 %. This patient is of interest because her muscle mass was only 17 % of body weight yet her whole-body synthesis rate was very high -at 310 mg protein/kg per h almost twice that in normal subjects, presumably because a larger proportion of her lean body mass consisted of visceral protein with a high rate of turnover.
Comparison of different protocols in different individuals
Whole-body protein synthesis in normal adults. There are four different variants of the method. The results are shown in Table 3 . With single oral dosage in the fasted state, synthesis is almost 20 % lower than in the fed state. The difference between these methods is 34 mg protein/kg per h (95 % CI 4, 64; P¼0·03). As in the study of Grove & Jackson (1995) multiple dosage gives rates 25 % lower than oral dosage, the difference being 42 mg protein/kg per h (95 % CI 21, 85; P¼0·05). The IV single dose, usually administered over 1 h, gives rates similar to oral dosage. With constant IV infusion the results are much lower, probably because these infusions were continued for 2 -3 d, which would allow a substantial amount of recycling, thus increasing the labelling and decreasing the estimate of flux. The variability between groups is high, suggesting that there were undetected differences in technique. In the largest group (A) the inter-individual CV is 21 %. The contrast between using the between-group SD and the within-group SD is seen most clearly with constant IV infusion fed (G), where protein synthesis in the three groups is similar (actual data 90, 98 and 104 mg protein/kg per h), but variation between individuals within each group was high (SD of actual data 28, 19 and 13 mg protein/kg per h, respectively).
Whole-body protein synthesis in various physiological states. The end-product method has been quite widely applied to subjects in different physiological states. Synthesis rates in this group are shown in Table 4 . In premature babies the average rate of synthesis is more than twice as high as in adults. One feature of studies in premature infants is that glycine may not be available for urea synthesis, so that urea gets zero or very low labelling (Jackson et al. 1981) . Authors have therefore reported data based on labelling of ammonia only. We have not included these data in Table 4 . However, an analysis of these studies (using the same method, multiple oral dose) shows a mean rate of protein synthesis of 404 mg protein/kg per h, not dissimilar from the mean of 444 mg protein/kg per h shown in Table 4 (JC Waterlow, unpublished results). These babies weighed approximately 2 kg and on average were growing at a rate of approximately 15 g/kg per d. If the new tissue contains 12 % protein they would be depositing about 75 mg protein/kg per h. Thus, synthesis far exceeds deposition; the same situation has been found in growing animals and in children recovering from malnutrition (Reeds & Harris, 1981) . Synthesis rates fall progressively as children become older and are growing less. In pregnancy the rate is similar to that in normal adults and does not appear to change as pregnancy progresses. Pregnancy, however, poses particular problems in respect of how best to express results. The interpretation can vary considerably depending on whether rates of synthesis are expressed as absolute values or relative to body weight or lean body mass (Duggleby & Jackson, 2002) . The average rate in the elderly is a little lower than in younger people; in one study in which the results in the two sexes were reported separately (Pannemans et al. 1995) , synthesis was substantially lower in women than in men even when the rates were based on lean body mass rather than on body weight.
Whole-body protein synthesis in pathological states. The results of thirty-nine studies are summarized in Table 5 . As with normal subjects, the values with the IV tracer tend to be lower than when the tracer is given orally. The synthesis rate in malnourished infants, at 132 mg/kg per h, is only about half that of recovered children (Table 4 ). In an interesting study by Golden & Golden (1992) , children were given varying amounts of Zn during the recovery period. The first measurements were made in the early stage of recovery, and so are not included in Table 5 . Their results suggest that Zn promotes protein synthesis. The undernourished adults do not show the same depression of synthesis as the infants, but the extent of their malnutrition was much less severe. Moreover, the Indian labourers in the study had less body fat and a lower proportion of muscle to nonmuscle tissue than controls, which would tend to raise their synthesis rates. The low synthesis rates per kg in obesity perhaps reflect the dilution of lean body mass by fat. Otherwise it is difficult to discern any pattern. The high synthesis rate in sickle cell disease may result from the constant replacement of erythrocytes, while the low rate in AIDS is presumably the consequence of an inactive immune system. Tomkins et al. (1983) showed that protein turnover rates were very high in children with severe infections, but this study was not included here because only ammonia was used as an end product.
Comparison of whole-body protein synthesis measured by the end-product and precursor methods. Use of the end-product method with glycine as a tracer is best supported by comparison with a method that rests on completely different assumptions, such at the precursor method with leucine -a-ketoisocaproic acid. Very briefly, in this method [ 13 C]leucine is given by constant IV infusion, usually with a priming dose so that plateau Stein et al. (1996) ; 2, Marchini et al. (1996) enrichment is achieved in 1 -2 h. Flux is calculated from the enrichment in plasma of a-ketoisocaproic acid, a transamination product of leucine that gives a better estimate than plasma leucine of the precursor activity at the site of synthesis. Oxidation, the equivalent of N excretion in the end-product method, is calculated by measuring the output of 13 CO 2 , allowing for some of it being retained in the body. Finally, as with the end-product method, synthesis is obtained by subtracting oxidation from flux.
Few comparisons of the two methods have been made in the same patients at the same time. Golden & Waterlow (1977) fed six elderly patients by nasogastric tube for 24 h, with [ 15 N]glycine added to the feed. In three of the subjects [ 14 C]leucine was given by IV infusion; in the other three it was added to the feed. If the results with leucine had been corrected by using a-ketoisocaproic acid, the two methods would have agreed to within about 10 %. Pacy et al. (1994) compared synthesis rates (Table 6 ) and found good agreement at the two higher levels of protein intake but not at the lowest. Pannemans et al. (1997) made a similar comparison in elderly women (Table 6 ). Interpretation of these results is complicated by differences in the route of dosage. Of interest is a study by Nissim et al. (1983) , who gave a pulse dose of [ 15 N]glycine and from compartmental analysis of the plasma decay curve calculated a synthesis rate of 147·5 mg protein/kg per h, compared with a rate of 121·9 from the end-product average. Although this study involved only a single tracer, it is a true comparison between precursor and end-product methods.
The other comparison that can be made is between the mean rates of protein synthesis obtained by the end-product method with those obtained by the 'gold standard' precursor method. The difficulty in comparing the two approaches is that there are so many variants of both methods. From a practical point of view, the most useful comparison is between the most used variants. For the end-product approach the method that has been preferred by most workers is the single oral dose of tracer in the fed state; for the precursor approach it is the single IV infusion. The data we have used for the precursor method are derived from an analysis of forty-three papers studying some 356 subjects. For the purposes of this comparison the fasting-feeding protocol (where the measurement is carried out over a period of fasting followed by a period of food intake) is regarded a single study. The results are shown in Table 7 .
The difference in the fed state is less than 10 %: 179 mg protein/kg per h by the end-product method v. 164 mg protein/kg per h by the precursor method. It is greater in the fasted state (difference 33 mg protein/kg per h; 95 % CI 13, 52; P¼0·0013). Thus there is a discrepancy in the effect of fasting that we cannot explain -no difference from feeding with the precursor method, quite a large difference by the end-product method. This is clearly a finding that needs further investigation.
An important finding is that the variability both between and within groups is lower with the precursor method, probably because the protocol is more rigidly standardized.
The flux ratio
The end-product method, however, does allow us to estimate the flux ratio. On Fern's hypothesis, the flux ratio is of interest because it could give information about the relative activity in two pathways that are metabolically and spatially separate. Table 8 shows the data in normal adults in fed and fasted states, with the four different variants of the end-product method and [
15 N]glycine. In some of the studies synthesis rates were reported rather than fluxes. In such cases the flux ratio was calculated as S A /S U . If the subjects were in N balance, and excretion was equal to intake, adding it to the values for synthesis would lead to a negligible difference between S A /S U and Q A /Q U . In addition, in some studies, mean Q A and mean Q U have been reported but not mean (Q A /Q U ). In forty-four of the studies, data were given for individuals. In thirty-seven of these (mean Q A )/(mean Q U ) differed from mean (Q A /Q U ) by less than 5 %. We have therefore accepted (mean Q A )/(mean Q U ) as a representative summary index of mean (Q A /Q U ) when that was all that was reported. The within-group SD could not be calculated as many papers did not report an SD for the flux ratio.
The flux ratios are all lower with IV than with oral dose, although the differences are not statistically significant except Golden & Golden (1992) ; 5, Waterlow et al. (1978b); 6, Jackson et al. (1983); 7, de Benoist et al. (1985) ; 8, Willommet et al. (1992) ; 9, Jackson et al. (2000); 10, Duggleby & Jackson (2001); 11, Arnal et al. (1999) ; 12, Golden & Waterlow (1977); 13, Pannemans et al. (1995); 14, Pannemans et al. (1997) . k Children were recovering or had recovered from malnutrition. { No difference in rates of protein synthesis using a single or multiple dosage, in separate subjects. ** In one study (Pannemans et al. 1995) results were given separately for both sexes: protein synthesis was 183 and 114 mg protein/kg per h for men and women, respectively. Glynn et al. (1987); 30. Powell-Tuck & Glynn (1985) ; 31, Jeevanandam et al. (1988); 32, Jeevanandam et al. (1987); 33, Jeevanandam et al. (1984); 34, Fearon et al. (1988) ; 35, Kondrup et al. (1997) ; 36, Richards et al. (1993); 37, Mihranian et al. (1983) ; 38, Dresler et al. (1987); 39, Lieberman et al. (1994) . k Not possible to calculate an SD or SD not reported in paper. { In this study protein intake was 1.8 and 2.3 g protein/kg per d for habitual and weight-reducing diets, respectively. ** SD reported in paper, therefore within-group SD.
† † In two studies, rates of protein synthesis were unusually high at 370 mg/kg per h. 0·36  170  26  5  128  31  5  10·6  129  21  6  75  17  6  0·77  174  17  5  176  33  5  19·6  129  8  6  108  25  6  1·59  193  7  6  209  78  5 A, Pacy et al. (1994) , young adults. Leucine given by continuous intravenous infusion. Data based on enrichment in plasma of a-ketoisocaproic acid. Glycine by intravenous dosage over 1 h. Both in fed state. B, Pannemans et al. (1997) , elderly women. Leucine by continuous intravenous infusion. Data based on enrichment in plasma of a-ketoisocaproic acid. Glycine by single oral dose. Both in fasted state.
for the single dose in the fasted state (B v. F): mean difference 50·4 (95 % CI 28, 73; P¼0·0007). This implies a tendency for the precursors of ammonia to be more highly labelled, and for those of urea to be less highly labelled with IV dosage, which is what would be expected on the basis of the Fern hypothesis. There is also a statistically significant difference between method A (carried out in the fed state) and method B (carried out during fasting). The mean difference is 38·5 (95 % CI 19, 58; P¼0·0004). This again suggests that in fasting the pattern of flux is biased towards peripheral tissues. In Table 9 are also collated data on the flux ratio in subjects in various physiological and pathological states. We took the same approach to the data as for Table 8 , described earlier. There is very little variation in the normal subjects, from premature infants to the elderly, which implies a remarkable degree of stability throughout life. In malnourished infants the ratio is low, suggesting a relatively high flux through the visceral pathway, in keeping with their reduced muscle mass. The same effect was found in undernourished male adults in whom, as mentioned earlier, muscle mass was greatly reduced (Soares et al. 1991 (Soares et al. , 1994 ).
An outstanding change is a high flux ratio in two groups, trauma and obesity, implying on our hypothesis a relatively greater flux through peripheral than visceral tissues. In trauma this is the opposite of what one would expect, since these subjects should be producing in the liver large amounts of acute-phase proteins (e.g. Preston et al. 1995) . Perhaps this result indicates enhanced activity of the immune system throughout the body. There are no studies on subjects with infection rather than trauma.
The finding of a high flux ratio in obese patients is surprising. The difference from the mean in normal subjects with single or multiple oral dosage in the fed state is highly significant (t ¼ 3·2). We have no explanation for this finding, which suggests a previously unrecognized difference in metabolism between normal and obese people, and clearly deserves further study.
The precursor and end-product methods are complementary; the choice between them will depend on the purpose of the exercise and on practical considerations. There are some results that cannot be obtained by the end-product method, such as consecutive fasting/feeding measurements or studies of C balance, both of which are major contributions of Young's group at Massachusetts Institute of Technology. On the other hand, the end-product k For references for results by the end-product method, see Table 3 rows A and B. { References for results by the precursor method will be presented in a forthcoming book (Waterlow, In Press) . Marchini et al. (1996) ; 2, Soares et al. (1991); 3, Jackson et al. (2000) ; 4, Gausseres et al. (1997) ; 5, Grove & Jackson (1995); 6, McNurlan et al. (1987); 7, Fern et al. (1985b); 8, Fern et al. (1984); 9, Fern & Garlick (1983); 10, Fern et al. (1981); 11, Soares et al. (1994) ; 12, Acheson et al. (1995); 13, Robinson et al. (1990); 14, Willommet et al. (1992); 15, Stein et al. (1996); 16, Stein et al. (1990); 17, Conway et al. (1995); 18, Bos et al. (2000); 19, Badaloo et al. (1989); 20, de Benoist et al. (1985) ; 21, Jackson et al. (1997); 22, Jackson et al. (1987) method may be the one of choice for population studies aimed at determining whole-body rates of protein synthesis and their functional correlates in genetically or environmentally different groups. We hoped also that the flux ratio would give interesting information about the partition of protein metabolism between peripheral and visceral tissues. This hope has been only partially fulfilled, but the results have raised some points for further investigation.
The practical pros and cons of the two methods are summarized in Table 10 . There is a powerful argument for using only ammonia as end product, particularly for field studies, since no blood samples are needed. A good example of the information that can be obtained with ammonia alone is a study by Tomkins et al. (1983) in Nigeria, which showed well-defined differences in whole-body protein synthesis and breakdown in children with varying degrees of infection and malnutrition. Another, more academic, advantage of ammonia Glynn et al. (1987); 27, Powell-Tuck & Glynn (1985) ; 28, Fearon et al. (1988) . k In one study (Jackson et al. 1983) flux ratio was 81 in children given 1·7 g protein/kg per d and was 47 in those given 0·7 g protein/kg per d. { In this study protein intake was 1·8 and 2·3 g protein/kg per d for habitual and weight-reducing diets, respectively ** Not possible to calculate an SD or SD not reported in paper. as end product is that its enrichment may undergo rapid and shortterm changes of a kind that cannot be observed with urea. In a study in which hourly feeds and [ 15 N]glycine were given for 36 h a step-like pattern was observed in which a plateau of ammonia enrichment occurred about 4 h after the start of feeding, followed by a second plateau during the night, suggesting a circadian process. The second plateau could be caused by increased breakdown of labelled protein during the night. Indications of such a step could be seen in figures reproduced by other authors (Catzeflis et al. 1985; Jeevanandam et al. 1985) .
No combination of pools turning over by first order kinetics could produce such a step. It was therefore suggested that it resulted from a pool of protein that turned over by life-cycle kinetics. Such a system, modelled by computer, produced curves that agreed quite well with those observed experimentally (Slevin et al. 1991) . It seemed possible that the life-cycle pool might consist of protein of the villous cells of the gastrointestinal mucosa. Its turnover could not be related in any simple way to feeding, since food was infused throughout the experiment. In a further study of this effect, subjects received hourly feeds + tracer for 36 h (Jackson et al. 1997) . They were divided into three groups, starting the experiment at 06.00 hours, noon or 18.00 hours. Enrichment of ammonia reached a plateau in about 4 h from the start; then at about midnight, regardless of the time at which the experiment started, the enrichment began to rise to a second plateau, which was achieved in about 4 h and maintained until the evening. At the second plateau the calculated flux was 71 % of that at the first plateau (Fig. 4) .
This pattern suggests a circadian rhythm in which the first phase lasts from about 06.00 hours to 18.00 hours and the second from 18.00 hours to 06.00 hours. In the second phase there is an increase in the enrichment of ammonia, which could arise in several ways: decreased breakdown of poorly labelled body protein or increased breakdown of highly labelled protein, as observed in the evidence for recycling (q.v.) , where very rapid turnover of even a small part of the total protein pool can have a significant effect on labelling of the precurser (K Slevin and JC Waterlow, unpublished results) . This breakdown could be occurring in a pool turning over by lifetime kinetics. There is not the evidence to decide between these possibilities.
It would be interesting to see if a similar pattern was found with a 24 h infusion of leucine in which feeding was continued throughout.
Circadian rhythms have been described in the secretion of some proteins by the liver (Marckmann et al. 1993) and by the exocrine pancreas (Maouyo et al. 1993) and in the turnover of bone (Eastell et al. 1992) . This is a subject that deserves further investigation.
Conclusion
Many problems remain about the metabolic basis of the end-product method. It is difficult to find a consistent explanation for some of the results in Table 1 : the differences between the estimates of flux by the oral and IV routes and the differences in flux ratio between different amino acids and routes of tracer dosage. One general point may be relevant: the first five amino acids in Table 1 are non-essential and therefore undergo de novo synthesis, which is not the case for the amino acids used as tracers in the precursor method. As explained earlier, de novo synthesis of the tracer amino acid will not affect the estimate of protein synthesis, but the location of de novo synthesis, central or peripheral, will have a profound effect on the flux ratio. We believe that these unexplained findings, derived from a single unique experiment, should not undermine confidence in the empirical usefulness of the method, but rather should stimulate further research.
At the end of the day the question of the validity of the results for whole-body protein turnover by either method is still an open one. Therefore we have to rely on the reasonable agreement between the two sets of results, based on different assumptions, that they are both measurements of a real biological functionwhole-body protein synthesis.
We dissent strongly from the view expressed by Bier (1989) in an important review: '. . .the approach of "validating" nitrogen flux calculations against related values derived from "primary" and "reciprocal" pool methods is unconvincing, since. . .protein inflow and outflow rates do not always agree with protein kinetic parameters obtained from rigorous solution of a more comprehensive model'. There can never be a fully comprehensive model of a system as complicated as the whole body; in the same paper Bier refers to '. . .a structurally and mathematically correct model as a reference. . .'. Such a 'correct' model is a chimera; one can but proceed by successive approximations, and when two approximations based on different assumptions agree reasonably well, that is one step forward.
Leaving aside the philosophical problem of defining what is true, we argue that the end-product method, applied in a strict and standardized way, provides a reasonable estimate of wholebody protein turnover. We hope to see it measured in the future in as wide a range of subjects as metabolic rate has been: in different ethnic groups, in old and young, in fat and thin people, tall and short, active and inactive. Protein turnover is a basic biological function and we need to know more about it.
